News + Filings Transactions Holdings
|
Schinazi Raymond F
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/10/2022 | PRECISION BIOSCIENCES INC | DTIL | Grant | Stock Option (Right to Buy) | 157k | $1.86 | $291.9k | | 05/10/2022 |
| 05/10/2021 | PRECISION BIOSCIENCES INC | DTIL | Grant | Stock Option (Right to Buy) | 32.8k | $8.07 | $264.7k | | 05/10/2021 |
| 05/04/2021 | Cocrystal Pharma, Inc. | COCP | Sale | Common Stock | 575k | $2.95 | $1.7M | | 05/04/2021 |
| 05/13/2020 | PRECISION BIOSCIENCES INC | DTIL | Grant | Stock Option (Right to Buy) | 41k | $6.62 | $271.7k | | 05/13/2020 |
| 10/25/2019 | Cocrystal Pharma, Inc. | COCP | Purchase | Common Stock | 7.9k | $1.15 | $9.1k | | 10/23/2019 |
| 10/24/2019 | Cocrystal Pharma, Inc. | COCP | Purchase | Common Stock | 5.1k | $1.15 | $5.9k | | 10/23/2019 |
| 10/23/2019 | Cocrystal Pharma, Inc. | COCP | Purchase | Common Stock | 3.9k | $1.04 | $4.1k | | 10/23/2019 |
| 04/01/2019 | PRECISION BIOSCIENCES INC | DTIL | Conversion | Series B Preferred Stock | 119.8k | $0.00 | $0 | By RFS Partners, LP | 04/01/2019 |
| 04/01/2019 | PRECISION BIOSCIENCES INC | DTIL | Conversion | Convertible Promissory Note | 0 | $13.60 | $0 | By RFS Partners, LP | 04/01/2019 |
| 04/01/2019 | PRECISION BIOSCIENCES INC | DTIL | Conversion | Common Stock | 56.1k | $0.00 | $0 | By RFS Partners, LP | 04/01/2019 |
| 04/01/2019 | PRECISION BIOSCIENCES INC | DTIL | Conversion | Common Stock | 36.9k | $13.60 | $502.5k | By RFS Partners, LP | 04/01/2019 |
| 03/27/2019 | PRECISION BIOSCIENCES INC | DTIL | Grant | Stock Option (Right to Buy) | 34.5k | $16.00 | $552.7k | | 03/27/2019 |
| 03/27/2019 | PRECISION BIOSCIENCES INC | DTIL | Other (acquisition) | Convertible Promissory Note | 0 | $13.60 | $0 | By RFS Partners, LP | 03/27/2019 |
| 09/21/2018 | Cocrystal Pharma, Inc. | COCP | Grant | Stock Options (Right to Buy) | 50k | $2.78 | $139k | | 09/21/2018 |
| 05/10/2018 | Cocrystal Pharma, Inc. | COCP | Grant | | 263.2k | $1.90 | $500k | By LP | 05/10/2018 |
| 05/10/2018 | Cocrystal Pharma, Inc. | COCP | Disposition | | 61.7k | $8.10 | $500k | By LP | 05/10/2018 |
| 05/10/2018 | Cocrystal Pharma, Inc. | COCP | Grant | | 10.2k | $1.90 | $19.4k | By LP | 05/10/2018 |
| 05/10/2018 | Cocrystal Pharma, Inc. | COCP | Exercise | | 263.2k | $1.90 | $500k | By LP | 05/10/2018 |
| 05/03/2018 | Cocrystal Pharma, Inc. | COCP | Grant | Common Stock | 420.7k | $1.90 | $799.4k | By LP | 05/03/2018 |
| 11/24/2017 | Cocrystal Pharma, Inc. | COCP | Grant | 8% Convertible Note | 1.9M | $0.27 | $500k | By LP | 11/24/2017 |
| 07/11/2017 | Cocrystal Pharma, Inc. | COCP | Exercise | Stock Options (Right to Buy) | 1.7M | $0.05 | $80.2k | | 07/11/2017 |
| 04/20/2017 | Cocrystal Pharma, Inc. | COCP | Grant | Common Stock | 4.2M | $0.24 | $1M | By LLC | 04/20/2017 |
| 09/01/2016 | Cocrystal Pharma, Inc. | COCP | Purchase | Common Stock | 4.9M | $0.41 | $2M | By LLC | 09/01/2016 |
| 03/15/2016 | Cocrystal Pharma, Inc. | COCP | Purchase | Common Stock | 2.9M | $0.51 | $1.5M | | 03/15/2016 |
| 04/21/2015 | Cocrystal Pharma, Inc. | COCP | Purchase | Common Stock | 3.5M | $0.92 | $3.2M | | 04/21/2015 |
| 04/13/2015 | Cocrystal Pharma, Inc. | COCP | Grant | | 350k | $1.17 | $409.5k | | 04/13/2015 |
| 03/03/2015 | Cocrystal Pharma, Inc. | COCP | Exercise | Series A Convertible Preferred Stock | 789.7k | $0.00 | $0 | | 03/03/2015 |
| 11/25/2014 | Cocrystal Pharma, Inc. | COCP | Grant | Series A Convertible Preferred Stock | 798.7k | $0.00 | $0 | | 11/25/2014 |
| 11/25/2014 | Cocrystal Pharma, Inc. | COCP | Grant | Stock Options (Right to Buy) | 1.7M | $0.05 | $85.3k | | 11/25/2014 |
| 11/25/2014 | Cocrystal Pharma, Inc. | COCP | Grant | Stock Options (Right to Buy) | 1.7M | $0.15 | $256k | | 11/25/2014 |
| 05/02/2007 | Pharmasset Inc | VRUS | Conversion | Common Stock | 246.1k | $0.00 | $0 | | 05/02/2007 |
| 05/02/2007 | Pharmasset Inc | VRUS | Conversion | Series A convertible preferred stock | 369.2k | $0.00 | $0 | | 05/02/2007 |
| 05/02/2007 | Pharmasset Inc | VRUS | Conversion | Common Stock | 246.1k | $0.00 | $0 | | 05/02/2007 |
| 05/02/2007 | Pharmasset Inc | VRUS | Conversion | Series A convertible preferred stock | 369.2k | $0.00 | $0 | | 05/02/2007 |
|